RARE is trading at $35.26 (up 4.6%) on a generally weak broader market, though no clear company-specific catalyst has been identified for the move.
- The stock continues to outperform a flat healthcare sector on above-average volume, suggesting sustained bullish sentiment rather than a new event.
- There are no new documented catalysts today, such as earnings releases, FDA announcements, or analyst updates, to explain the price action.